Cetera Advisor Networks’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
CI
KWM
FCBT
Cetera Advisor Networks's XPH Position: Q1 2024 in Review
Cetera Advisor Networks reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 33% in Q1 2024, selling an estimated $160K and leaving 7,637 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.
Cetera Advisor Networks first reported a position in XPH in Q3 2018 and has held it in 8 quarters since. The position peaked at $472K in Q4 2023. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.
- Cetera Advisor Networks held 7,637 shares of State Street SPDR S&P Pharmaceuticals ETF worth $329K as of Q1 2024.
- Cetera Advisor Networks sold 3,710 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2024, an estimated $160K.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2221 holding.
- Cetera Advisor Networks first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2018 and has held it in 8 quarters since.
- Cetera Advisor Networks's State Street SPDR S&P Pharmaceuticals ETF position peaked at $472K in Q4 2023.
- 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.
Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.